Lorenzo Subissi

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (87)

• Learning from COVID-19, MERS and SARS to build sustainable coronavirus disease threat management
  Nature Health 2026 DOI: 10.1038/s44360-026-00144-8
  +Save
• Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications
  eClinicalMedicine 2026 DOI: 10.1016/j.eclinm.2026.103871
  +Save
• Mpox Clade IIb Virus Introduction into Kinshasa, Democratic Republic of the Congo, July 2025
  Viruses 2026 DOI: 10.3390/v18010087
  +Save
• Mpox Clade IIb Virus Introduction into Kinshasa, Democratic Republic of the Congo, July 2025
  2025 DOI: 10.20944/preprints202511.1811.v1
  +Save
• Clade I mpox virus genomic diversity in the Democratic Republic of the Congo, 2018–2024: Predominance of zoonotic transmission
  Cell 2025 DOI: 10.1016/j.cell.2024.10.017
  +Save
• Clade Ia Monkeypox Virus Linked to Sexual Transmission, Democratic Republic of the Congo, August 2024
  Emerging Infectious Diseases 2025 DOI: 10.3201/eid3105.241690
  +Save
• Clinical Applications of AI in Sexually Transmitted Infection and Anogenital Dermatoses in Sexual Health: A Systematic Review and Meta-Analysis
  Research Square 2025 DOI: 10.21203/rs.3.rs-6002285/v1
  +Save
• Concurrent outbreaks of mpox in Africa—an update
  Lancet 2025 DOI: 10.1016/S0140-6736(24)02353-5
  +Save
• Global genomic surveillance of monkeypox virus
  Nature Medicine 2025 DOI: 10.1038/s41591-024-03370-3
  +Save
• Rising mpox trends in DR Congo: the neglected spread of an epidemic
  Lancet 2025 DOI: 10.1016/S0140-6736(25)00137-0
  +Save
• A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories
  Viruses 2024 DOI: 10.3390/v16121936
  +Save
• An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution
  Lorenzo Subissi, James Richard Otieno, Nathalie Worp +55 more
  Nature Medicine 2024 DOI: 10.1038/s41591-024-02949-0
  +Save
• Adherence of SARS-CoV-2 Seroepidemiologic Studies to the ROSES-S Reporting Guideline During the COVID-19 Pandemic
  Influenza and Other Respiratory Viruses 2024 DOI: 10.1111/irv.13283
  +Save
• Clade I Mpox virus genomic diversity in the Democratic Republic of the Congo, 2018 - 2024: Predominance of Zoonotic Transmission
  Medrxiv 2024 DOI: 10.1101/2024.08.13.24311951
  +Save
• Co-circulation of Clade Ia and Ib monkeypox virus in Kinshasa Province, Democratic Republic of the Congo, July - August 2024
  Medrxiv 2024 DOI: 10.1101/2024.09.03.24312937
  +Save
• Co-circulation of monkeypox virus subcladesIa and Ib in Kinshasa Province, Democratic Republic of the Congo, July to August 2024
  Eurosurveillance 2024 DOI: 10.2807/1560-7917.ES.2024.29.38.2400592
  +Save
• Epidemiology and Phylogenomic Characterization of Distinct 2023 and 2024 Mpox outbreaks in Kinshasa, Democratic Republic of the Congo - Evidence for increasingly sustained human-to-human transmission of subclade Ia
  Medrxiv 2024 DOI: 10.1101/2024.11.15.24317404
  +Save
• First imported Cases of MPXV Clade Ib in Goma, Democratic Republic of the Congo: Implications for Global Surveillance and Transmission Dynamics
  Medrxiv 2024 DOI: 10.1101/2024.09.12.24313188
  +Save
• Global genomic surveillance of monkeypox virus
  Medrxiv 2024 DOI: 10.1101/2024.08.15.24312031
  +Save
• Human mpox: global trends, molecular epidemiology and options for vaccination
  Pathogens and Global Health 2024 DOI: 10.1080/20477724.2023.2258641
  +Save